Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
Chanchal Sharma, Hanwoong Woo, Sang Ryong Kim
Biomedicines (2022) Vol. 10, Iss. 4, pp. 742-742
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 90
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 58
Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment
Xiaoyang Ma, Yoon-Jung Shin, Jong-Wook Yoo, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 293-303
Open Access | Times Cited: 35
COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 28
siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
Muhammad Imran Sajid, Fahad Sultan Sheikh, Faiza Anis, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114968-114968
Closed Access | Times Cited: 23
The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Zhirui Li, Zixuan Fan, Qian Zhang
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 1, pp. 13-32
Closed Access | Times Cited: 12
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease
Junjian Zeng, Zhiqiang Liao, Hanqin Yang, et al.
Neurobiology of Disease (2024) Vol. 193, pp. 106461-106461
Open Access | Times Cited: 12
Melatonin: A potential nighttime guardian against Alzheimer’s
Z Zhang, Pei Xue, Barbara B. Bendlin, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 10
Cellular junction dynamics and Alzheimer’s disease: a comprehensive review
Keyvan Asghari, Zahra Niknam, Shadi Mohammadpour-Asl, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 9
Bridging the gap: glucose transporters, Alzheimer’s, and future therapeutic prospects
Mai Albaik, Dalaa Sheikh Saleh, Dana Kauther, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Hyperintensity of the left piriform cortex and amygdala on T2-weighted FLAIR images in patients with probable Alzheimer’s disease correlates with cerebral cortical atrophy
Hideo Ishizaka, Akiko Sekine, Minoru Naka, et al.
Acta Radiologica Open (2025) Vol. 14, Iss. 2
Open Access
Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer’s Disease: A Recent Systematic Review
Constantin Munteanu, Daniel Andrei Iordan, Mihail Hoteteu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15481-15481
Open Access | Times Cited: 11
Nanomedicine-based immunotherapy for Alzheimer's disease
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104973-104973
Closed Access | Times Cited: 18
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
Alicia García‐Culebras, María Isabel Cuartero, Carolina Peña‐Martínez, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 777-798
Open Access | Times Cited: 10
Obesity in Late-Life as a Protective Factor Against Dementia and Dementia-Related Mortality
Ginny Natale, Yun Zhang, D. Hanes, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2023) Vol. 38
Open Access | Times Cited: 9
Thinking outside the black box: are the brain endothelial cells the new main target in Alzheimer’s disease?
Enrique Estudillo, Adolfo López-Ornelas, Alejandro Rodríguez-Oviedo, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2592-2598
Open Access | Times Cited: 7
Modulation of microRNAs through Lifestyle Changes in Alzheimer’s Disease
Paola Pinto-Hernandez, Juan Castilla‐Silgado, Almudena Coto-Vilcapoma, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3688-3688
Open Access | Times Cited: 7
T Cells Trafficking into the Brain in Aging and Alzheimer’s Disease
Yue-Zhang Ma, Jia-Xin Cao, Yi-Shu Zhang, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 2
Intrathecal Immunoselective Nanopheresis for Alzheimer’s Disease: What and How? Why and When?
Manuel Menéndez‐González
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10632-10632
Open Access | Times Cited: 2
From Plaques to Pathways in Alzheimer’s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis
Sarah Kazemeini, Ahmed Nadeem-Tariq, Ryan M. Shih, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11720-11720
Open Access | Times Cited: 2
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Anna Maggiore, Valentina Latina, Maria D’Erme, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102578-102578
Open Access | Times Cited: 2
The Quest for Neurodegenerative Disease Treatment—Focusing on Alzheimer’s Disease Personalised Diets
Matei Palimariciuc, Ioana-Miruna Balmuș, Bogdan Gireadă, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1519-1535
Open Access | Times Cited: 5
Protective effects of Tenebrio molitor and Protaetia brevitarsis seulensis extracts on aging: Regulation of blood–brain barrier, amyloid β plaques, and intestinal inflammation in D-galactose-induced aging mice
Ngoc Buu Trân, Haeseong Lee, Sook-Jeong Lee
Journal of Functional Foods (2024) Vol. 119, pp. 106333-106333
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top